Showing results (1-10 of 329) with videos related to
Sort By:
Pageof 33
Cancer Journal (Sudbury, Mass.)|September 22, 2015
Epidermal Growth Factor Receptor-Mutant Lung Cancer: New Drugs, New Resistance Mechanisms, and Future Treatment OptionsZofia Piotrowska, Lecia V SequistJAMA Oncology|May 20, 2016
Treatment of EGFR-Mutant Lung Cancers After Progression in Patients Receiving First-Line EGFR Tyrosine Kinase Inhibitors : A ReviewZofia Piotrowska, Lecia V SequistCancer Discovery|July 24, 2021
Targeting EGFR Exon 20 Insertions in Non-Small Cell Lung Cancer: Recent Advances and Clinical UpdatesCatherine B Meador, Lecia V Sequist, Zofia PiotrowskaJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A ReviewAndrew J Piper-Vallillo, Lecia V Sequist, Zofia PiotrowskaThe Oncologist|April 29, 2018
Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung CancersMelin J Khandekar, Zofia Piotrowska, Henning Willers, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2015
Pattern of Failure Analysis in Metastatic EGFR-Mutant Lung Cancer Treated with Tyrosine Kinase Inhibitors to Identify Candidates for Consolidation Stereotactic Body Radiation TherapyHani Al-Halabi, Karl Sayegh, Subba R Digamurthy, et al.Cancer Research|September 10, 2020
Modeling Resistance and Recurrence Patterns of Combined Targeted-Chemoradiotherapy Predicts Benefit of Shorter Induction PeriodDavid M McClatchy, Henning Willers, Aaron N Hata, et al.The Oncologist|April 5, 2007
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerLecia V SequistJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patientsLecia V SequistCancers|September 22, 2019
Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung CancerSubba R Digumarthy, Dexter P Mendoza, Atul Padole, et al.Pageof 33